Complete Guide
KLOW Combo: A Complete Guide to the Four-Peptide Healing Blend
Published by Peptara Labs · Updated · How we research and check our pages
KLOW is a four-peptide blend in a single vial: BPC-157, TB-500, GHK-Cu, and KPV. Each component is studied separately for a different angle of tissue, gut or skin work; the combination itself has no published human trial.
This guide covers what each component is studied for, why a blend instead of singles, what the research describes, side effects, contraindications, and storage. It is educational and does not set a dose for anyone.
Quick facts
KLOW at a glance
| Attribute | Detail |
|---|---|
| What it is | A four-peptide blend: BPC-157, TB-500, GHK-Cu and KPV |
| Class | Combination repair and skin peptide |
| Studied for | Tissue, gut and skin repair, per each component (Gwyer et al., 2019; Goldstein et al., 2012) |
| Vial size | 80 mg lyophilized |
| Reconstitution | 2 ml bacteriostatic water |
| Storage | Room temperature sealed; refrigerate at 2 to 8 C once mixed, use within about 30 days |
| Research status | Component evidence is largely preclinical; the blend itself has no published human trial |
See the KLOW product page, current KLOW price per vial, the reconstitution calculator, or the best peptides for injury healing overview.
Section 1
What is in the KLOW blend?
KLOW combines four well-known repair peptides. Each is studied for a different part of recovery across tissue, gut, and skin. The science behind each component is the same science covered in their individual guides, and it is largely preclinical plus user experience; the blend itself has no published human trial.
BPC-157
Studied in preclinical models of gut and musculoskeletal soft-tissue healing, with a mechanism discussed around angiogenesis and collagen signaling (Gwyer et al., 2019).
TB-500
The thymosin beta-4 fragment studied as a regenerative peptide for soft tissue, via its role in actin binding and cell migration (Goldstein et al., 2012).
GHK-Cu
A copper peptide studied for skin renewal, collagen, and wound healing, with one of the deeper research bases among skin peptides (Pickart and Margolina, 2018).
KPV
A short peptide fragment of alpha-MSH studied for anti-inflammatory activity in murine models of inflammatory bowel disease, adding an anti-inflammatory angle to the blend (Kannengiesser et al., 2008).
Section 2
Blend vs Singles: When KLOW Makes Sense
KLOW makes sense when you want broad recovery across tissue, gut, and skin at the same time and would rather manage one vial than three or four. The convenience is real: one reconstitution, one injection, one schedule.
Singles make sense when you have a specific, isolated target and want to push that one component higher than a fixed blend ratio allows, or when cost per goal matters more than convenience.
Message us and we will point you at what the research describes for the blend and for each single. Which one fits your goal is a question for a licensed physician, and we would rather send you to the research than push the blend.
Section 3
What does the research describe?
KLOW is a blend, so its evidence base is the combined evidence of its components, which is largely preclinical (Gwyer et al., 2019; Goldstein et al., 2012; Pickart and Margolina, 2018; Kannengiesser et al., 2008). There is no published human trial of the blend itself. This guide is educational and does not state an amount, a frequency or a cycle for any person. What to take, if anything, is a decision for a qualified clinician.
One vial instead of several
Because the blend already contains BPC-157 and GHK-Cu, running those as separate vials at the same time duplicates them. That is the practical case for the blend over singles, covered above.
How injectable doses are measured
Injectable peptides are drawn on an insulin syringe marked in units, never in millilitres by eye. How many units a given milligram amount fills depends on how the vial is reconstituted, so the same amount lands on a different unit mark at a different diluent volume. Our reconstitution guide and calculator do that milligram-to-units math for any amount a clinician specifies.
Section 4
Timing and Daily Use
A blend combines peptides with different timing preferences, so a single vial delivers all four together rather than on separate schedules.
Section 5
Side Effects: What to Expect
Commonly reported
- Injection-site irritation: mild and temporary.
- Temporary fatigue: occasionally reported, usually early in a cycle.
The honest framing on safety
The components of KLOW are individually well tolerated in reports. Because GHK-Cu is part of the blend, people with a copper allergy or copper-metabolism disorder (such as Wilson disease) should avoid KLOW. The angiogenesis caution noted for BPC-157 and TB-500 applies here too: those with active cancer or a cancer history should discuss the mechanism with a physician first.
As with all research peptides, there are no large registered human safety trials for the blend. Start conservative and run defined cycles.
Section 6
Stacking and Sequencing
KLOW is already a stack in a vial, so the main question is what to run alongside it rather than what to add inside it.
KLOW + CJC-1295 / Ipamorelin
Broad tissue repair plus growth-hormone-driven recovery and sleep. A sensible pairing for someone in a heavy training or rehab block.
Do not double up the components
The blend already contains BPC-157, TB-500 and GHK-Cu, so running them separately alongside KLOW duplicates components and wastes product without adding benefit.
Section 7
Contraindications and Cautions
- Copper allergy or Wilson disease: do not use, because of the GHK-Cu component
- Active cancer or a cancer history: discuss the angiogenesis mechanism with a physician first
- Pregnancy or breastfeeding: avoid, as there is no safety data
- Any serious medical condition or prescription regimen: consult your physician before starting
KLOW is a research compound, not an approved treatment for any condition.
Section 8
Common Mistakes to Avoid
- Doubling up on components. BPC-157 and GHK-Cu are already in the blend, so running them separately duplicates them.
- Ignoring the copper caution. KLOW contains GHK-Cu. Anyone with a copper-metabolism disorder or allergy should not use it.
- Measuring in mL by eye. Injectable amounts are measured in units on an insulin syringe. The reconstitution calculator converts any clinician-specified amount into units.
- Expecting a single-target solution. KLOW is built for broad recovery. For one isolated issue, a single peptide may suit better.
- Reconstitution errors. The standard technique uses bacteriostatic water added down the side of the vial, a gentle swirl rather than shaking, and refrigeration once reconstituted.
Section 9
Storage and Reconstitution
The lyophilized vial is stable at room temperature before reconstitution. Avoid direct sunlight and heat. For longer storage, refrigerate. Do not freeze the lyophilized powder.
Once reconstituted with bacteriostatic water, store refrigerated at 2-8 degrees C and use within about 30 days. The solution may carry a faint blue tint from the GHK-Cu component; that is normal. Discard if cloudy.
- The vial top is wiped with an alcohol swab.
- 2ml of bacteriostatic water is drawn into a syringe.
- The standard technique adds the BAC water slowly down the inside wall of the vial, not directly onto the powder.
- The vial is swirled gently, not shaken.
- The powder is left to fully dissolve before use.
See the Peptara reconstitution guide for an interactive calculator and walkthrough.
Section 10
Frequently Asked Questions
Why use a blend instead of single peptides?
Convenience and coverage. Running BPC-157, TB-500, and GHK-Cu separately means three vials, three reconstitutions, and three injections. KLOW puts a balanced ratio of all of them, plus KPV, into one injection. For broad recovery across tissue, gut, and skin at once, it simplifies the routine. If you have a single specific target, a solo peptide may be more cost-effective.
Should I still run BPC-157 or GHK-Cu separately while on KLOW?
Usually not. The blend already contains both, so doubling up is redundant and wastes product. KLOW is designed to replace separate BPC-157 and GHK-Cu while you run it. If you have a specific reason to push one component higher, that is a question for a licensed physician rather than something this guide sets.
What is KPV and why is it in the blend?
KPV is a short anti-inflammatory peptide, a fragment of alpha-MSH. It complements the three repair peptides by adding an anti-inflammatory angle, which supports cleaner, faster recovery alongside the tissue and skin work the others do.
Is Peptara KLOW real?
Every vial comes with a third-party Certificate of Analysis confirming purity. We source from verified manufacturers and provide lab documentation on request. Message us on WhatsApp before ordering if you want to see a COA first.
How long does one KLOW vial last?
The vial holds 80mg of the KLOW blend. Reconstituted with 2ml of bacteriostatic water that is 40mg per ml, so any amount converts straight into syringe units. How long it lasts depends entirely on the amount and the frequency, and this site does not work out how many vials a reader needs, because that would require picking a dose. A dose is a decision for a qualified clinician, and the reconstitution calculator converts any amount they specify into units.
Do I need to refrigerate KLOW?
The lyophilized vial is stable at room temperature before reconstitution. Once reconstituted with bacteriostatic water, store it in the refrigerator (2-8 degrees C) and use within about 30 days. Storage instructions come with every order.
Research and citations
Peer-reviewed sources
- Pickart L, Margolina A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. doi.org/10.3390/ijms19071987
- Gwyer D, Wragg NM, Wilson SL. (2019). Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell and Tissue Research. doi.org/10.1007/s00441-019-03016-8
- Goldstein AL, Hannappel E, Sosne G, Kleinman HK. (2012). Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opinion on Biological Therapy. doi.org/10.1517/14712598.2012.634793
- Kannengiesser K, et al. (2008). Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases. doi.org/10.1002/ibd.20334
Citations refer to the peer-reviewed publications these figures are taken from. Every dose range reported on this site is the range a named study used. Not a substitute for medical advice.
A note on evidence
Research status
KLOW is a blend, so its evidence base is the combined evidence of its components. See the individual guides for more: BPC-157, TB-500, and GHK-Cu.
The component evidence is largely preclinical plus user experience; there is no published human trial of the blend itself. This guide reflects published research and Peptara Labs customer protocol experience. Not a substitute for medical advice. Consult a qualified physician before starting any peptide protocol.
Ready to Start Your KLOW Protocol?
KLOW Combo orders include a 60-day money back guarantee: verified purity and certificate of analysis on request, or your money back, plus direct WhatsApp support throughout your cycle.
Order KLOW ComboSame-day HCMC delivery · 1-3 days nationwide in Vietnam · Free shipping